Injection of recombinant FcαRI/CD89 in mice does not induce mesangial IgA deposition

Nephrology Dialysis Transplantation

Volumn 19, Issue 11, 2004, Pages 2729-2736

  van der Boog, Paul J M ^a   van Kooten, Cees ^a   van Zandbergen, Ger ^a   Klar Mohamad, Ngaisah ^a   Oortwijn, Beatrijs ^a   Bos, Nico A ^b   van Remoortere, Alexandra ^a   Hokke, Cornelis H ^a   de Fijter, Johan W ^a   Daha, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

CD89; IgA; IgA nephropathy; Mouse; Receptor

Indexed keywords

ANTIGEN; CD89 ANTIGEN; CHIMERIC PROTEIN; FC RECEPTOR; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; FC(ALPHA) RECEPTOR; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CLINICAL FEATURE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOGENESIS; IN VITRO STUDY; LIVER; MACROPHAGE; MESANGIUM; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SURFACE PLASMON RESONANCE; TISSUE SECTION; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; FLOW CYTOMETRY; METABOLISM;

ANIMALS; ANTIGENS, CD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; IMMUNOGLOBULIN A; MICE; MICE, INBRED BALB C; RECEPTORS, FC; RECOMBINANT PROTEINS;

EID: 8344262361     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh459     Document Type: Article

References (21)

1. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-215
2. de Fijter JW, Eijgenraam JW, Braam CA et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952-961
3. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085
4. Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. The N glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med 2000; 191: 2171-2182
5. Westerhuis R, van Zandbergen G, Verhagen NA, Klar-Mohamad N, Daha MR, van Kooten C. Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). J Am Soc Nephrol 1999; 10: 770-778
6. McDonald KJ, Cameron AJ, Allen JM, Jardine AG. Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun 2002; 290: 438-442
7. Moura IC, Centelles MN, Arcos-Fajardo M et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001; 194: 417-425
8. Launay P, Grossetete B, Arcos-Fajardo M et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191: 1999-2009
9. van der Boog PJ, de Fijter JW, van Kooten C et al. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy. Kidney Int 2003; 63: 514-521
10. van Zandbergen G, Westerhuis R, Mohamad NK, van de Winkel JG, Daha MR, van Kooten C. Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89. J Immunol 1999; 163: 5806-5812
11. Hermann P, Blanchard D, Saint-Vis B et al. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur J Immunol 1993; 23: 961-964
12. Hiemstra PS, Gorter A, Stuurman ME, van Es LA, Daha MR. Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 1987; 17: 321-326
13. van Dixhoorn MG, Getter A, Sato T et al. Induction of microhematuria by an IgA isotype switch variant of a monoclonal anti-Thy-1.1 antibody in the rat. Kidney Int 1996; 50: 1612-1623
14. Bos NA, Bun JC, Popma SH et al. Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria. Infect Immun 1996; 64: 616-623
15. Reterink TJ, van Zandbergen G, van Egmond M et al. Size-dependent effect of IgA on the IgA Fc receptor (CD89). Eur J Immunol 1997; 27: 2219-2224
16. Chintalacharuvu SR, Nagy NU, Sigmund N, Nedrud JG, Amm ME, Emancipator SN. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 2001; 126: 326-333
17. Emancipator SN, Gallo GR, Lamm ME. Experimental IgA nephropathy induced by oral immunization. J Exp Med 1983; 157: 572-582
18. Rifai A, Small PA Jr, Teague PO, Ayoub EM. Experimental IgA nephropathy. J Exp Med 1979; 150: 1161-1173
19. Coppo R, Mazzucco G, Martina G et al. Gluten-induced experimental IgA glomerulopathy. Lab Invest 1989; 60: 499-506
20. Pleass RJ, Dunlop JI, Anderson CM, Woof JM. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fcalpha receptor (FcalphaR) CD89. J Biol Chem 1999; 274: 23508-23514
21. Lum LG, Muchmore AV, O'Connor N, Strober W, Blaese RM. Fc receptors for IgA on human B, and human non-B, non-T lymphocytes. J Immunol 1979; 123: 714-719